跳至主要内容
临床试验/PACTR201901543722087
PACTR201901543722087已完成未知

asik-induced corneal changes after correction of hyperopia with and without application of Mitomycin C

Department of ophthalmology Faculty of Medicine Suez Canal University0 个研究点目标入组 68 人开始时间: 2019年1月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
68

研究概览

简要总结

Better predictability was noted in group A than in group B at the 6 month and 12 month follow-up visits, with a mean cycloplegic refraction SE of +0.5 ± 0.31 D in group A and +0.67 ± 0.39 D in group B at the 6 month visit, and +0.63 ± 0.37 D in group A and +0.89 ± 0.48 D in group B at the 12 month visit. The efficacy of the treatment at the end of the follow up period was better in group A than in group B. Group A showed fewer topographic corneal changes than group B.

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Hyperpic patients
  • +1 to +6 D
  • Stable refraction

排除标准

  • Previous ocular disease
  • Systemic diseases that affect stability of refraction
  • systemic disease that may affect corneal healing
  • Topographic changes that prevent Lasik

研究者

发起方
Department of ophthalmology Faculty of Medicine Suez Canal University

相似试验